Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES
Market for Our Common Stock
Our common stock is traded on the NASDAQ Global Select Market under the symbol “OMCL.”
Stockholders
There were 78 registered stockholders of record as of February 18, 2022. A substantially greater number of stockholders are beneficial holders, whose shares of record are held by banks, brokers, and other financial institutions.
Dividend Policy
We have never declared or paid any cash dividends on our common stock. We currently expect to retain any future earnings for use in the operation and expansion of our business and do not anticipate paying any cash dividends on our common stock in the foreseeable future.
Performance Graph
The following graph compares total stockholder returns for Omnicell’s common stock for the past five years to three indexes: the NASDAQ Composite Index, the NASDAQ Health Care Index, and the NASDAQ Health Services Index. The graph assumes $100 was invested in each of Omnicell’s common stock, the NASDAQ Composite Index, the NASDAQ Health Care Index, and the NASDAQ Health Services Index as of the market close on December 31, 2016. The total return for Omnicell’s common stock and for each index assumes the reinvestment of all dividends, although cash dividends have never been declared on Omnicell’s common stock, and is based on the returns of the component companies weighted according to their capitalization as of the end of each annual period.
The NASDAQ Composite Index tracks the aggregate price performance of equity securities traded on The NASDAQ Stock Market. The NASDAQ Health Care Index and NASDAQ Health Services Index tracks the aggregate price performance of healthcare and health services equity securities. Omnicell’s common stock is traded on The NASDAQ Global Select Market and is a component of both indexes. The stock price performance shown on the graph is based on historical results and should not be relied upon as an indication of future price performance.
39
Table of Contents
COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN (1) (2)
Among Omnicell, Inc., the NASDAQ Composite Index, the NASDAQ Health Care Index, and
the NASDAQ Health Services Index
_________________________________________________
(1) $100 invested on December 31, 2016 in stock or index, including reinvestment of dividends.
(2) This section is not deemed “soliciting material” or to be “filed” with the SEC and is not to be incorporated by reference into any filing of Omnicell, Inc. under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.
Year Ended December 31,
2016 2017 2018 2019 2020 2021
Omnicell, Inc. $ 100.00 $ 143.07 $ 180.65 $ 241.06 $ 354.04 $ 532.27
NASDAQ Composite 100.00 129.64 125.96 172.17 249.51 304.85
NASDAQ Health Care 100.00 126.86 125.46 151.60 190.16 186.02
NASDAQ Health Services 100.00 116.65 140.03 190.67 307.73 218.38
Stock Repurchase Program
We did not repurchase any shares of our common stock during the year ended December 31, 2021. Refer to Note 15, Stock Repurchase Program , of the Notes to Consolidated Financial Statements in this Annual Report on Form 10-K for additional information.
Equity Offerings
Refer to Note 16, Equity Offerings , of the Notes to Consolidated Financial Statements in this Annual Report on Form 10-K for additional information.
40
Table of Contents
ITEM 6. [Reserved]